Kestra Medical Technologies, Ltd.
KMTS
$16.55
-$0.42-2.48%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.23M | 15.09M | 13.75M | 13.75M | 10.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.23M | 15.09M | 13.75M | 13.75M | 10.05M |
| Cost of Revenue | 9.60M | 8.54M | 8.73M | 8.73M | 8.66M |
| Gross Profit | 7.63M | 6.55M | 5.02M | 5.02M | 1.40M |
| SG&A Expenses | 50.46M | 23.80M | 20.34M | 20.34M | 17.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.45M | 35.69M | 32.53M | 32.53M | 30.40M |
| Operating Income | -48.21M | -20.60M | -18.78M | -18.78M | -20.35M |
| Income Before Tax | -51.01M | -21.74M | -20.46M | -20.46M | -22.31M |
| Income Tax Expenses | 102.00K | 18.00K | 7.50K | 7.50K | -27.00K |
| Earnings from Continuing Operations | -51.11M | -21.76M | -20.47M | -20.47M | -22.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -942.00K | 250.00K | 346.00K | 346.00K | -- |
| Net Income | -52.05M | -21.51M | -20.13M | -20.13M | -22.28M |
| EBIT | -48.21M | -20.60M | -18.78M | -18.78M | -20.35M |
| EBITDA | -46.38M | -18.71M | -16.66M | -16.66M | -16.85M |
| EPS Basic | -2.25 | -1.25 | -217.18 | -217.18 | -1.22 |
| Normalized Basic EPS | -1.34 | -0.67 | -117.61 | -117.61 | -0.65 |
| EPS Diluted | -2.25 | -1.25 | -217.18 | -217.18 | -1.22 |
| Normalized Diluted EPS | -1.34 | -0.67 | -117.61 | -117.61 | -0.65 |
| Average Basic Shares Outstanding | 24.58M | 19.89M | 105.80K | 105.80K | 19.89M |
| Average Diluted Shares Outstanding | 24.58M | 19.89M | 105.80K | 105.80K | 19.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |